You are here

HTG Molecular to Present Corporate Overview at the 8th Annual SVB Leerink Global Healthcare Conference

TUCSON, Ariz., Feb. 20, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview the 8th Annual SVB Leerink Global Healthcare Conference, being held in New York, NY on February 27 – March 1, 2019.
Wednesday, February 20, 2019 - 08:00